Global Clinical Trials Imaging Market is Expected to USD 981.53 Million by 2020

Date: 2015-09-29

“The global clinical trials imaging market is expected to USD 981.53 million by 2020 from USD 724.87 million in 2015, at a CAGR of 6.25% between 2015 and 2020. By product, the market includes services & software. The services product segment is further classified into operational imaging services, systems & technology, reader services & design consulting. Based on modality, the market is segmented into CT, MRI, ultrasound, PET, X-rays, ECHO ad other modalities. The CT segment will hold the largest share of the clinical trials imaging market in 2015. 

The growth of this market is mainly driven by growth in pharmaceutical & biotechnology industries, increase in R&D funding and increasing number of CROs. The high growth potential in emerging markets, provides new growth opportunities and development of innovative new imaging modalities, contrast agents, molecular probes & radiopharmaceuticals provides new growth trends to players in the clinical trials imaging market. Rising demand of multimodality imaging technology in clinical trials is the major trend of this market.


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample